Contract A207_PO-0440900-V3

The University of Virginia awarded a contract to Eurofins Genomics LLC on August 8, 2026, for the procurement of synthetic oligonucleotide products. The contract, designated A207_PO-0440900-V3, carries a cumulative value of thirteen dollars and encompasses three distinct line items for salt-free, 25-base oligonucleotide sequences. The specific products include SMWT1-TGACCCCATCTCTTCACTCC, SMWT2-AACTCCACGACCACCTCATC, and phCREAS1-AGTCCCTCACATCCTCAGGTT, with each product ordered in quantities of four units at one dollar per unit.

Eurofins Genomics LLC, the prime contractor, is tasked with delivering the oligonucleotide products directly to the University of Virginia buyer. The contract documentation does not specify a defined period of performance beyond the award date, nor does it identify a specific county within Virginia or an alternate place of performance. Given the specialized nature of the synthetic DNA sequences and the contracting organization's research mission, these materials are likely intended for molecular biology or genomic research applications conducted by the University of Virginia.